CMS proposes RAPID device coverage pathway to sync evidence with FDA, shorten Medicare timelines, and boost early collaboration with manufacturers.
CMS proposes RAPID device coverage pathway to sync evidence with FDA, shorten Medicare timelines, and boost early collaboration with manufacturers.
The EO marks a shift toward individualized decision‑making in childhood vaccination.
New CMS rule bars federal dollars from covering puberty blockers, hormones, and surgeries for minors, citing safety concerns and insufficient evidence.
Federal Medicaid rules exclude homelessness from automatic exemptions, leaving vulnerable populations at risk of losing coverage.
The DOJ’s Antitrust Division is returning to targeted Second Request investigations.
The Third Circuit has ruled a fax about a blood thinner could qualify as an unsolicited advertisement under the TCPA.
FDA sets FY 2027 medical device user fees, updating submission and registration costs under MDUFA V and outlining small business reductions.
A new study found proposed Medicare drug pricing models may rely on prices from relatively few international markets.